IRVINE,
Calif., Jan. 5, 2023 /PRNewswire/ -- Edwards
Lifesciences Corporation (NYSE: EW) today announced it will
participate in the J.P. Morgan Healthcare Conference on
Tuesday, Jan. 10, 2023.
Michael A. Mussallem, chairman and chief executive
officer, is scheduled to present at 11:15
a.m. PT. Bernard Zovighian, president and incoming
chief executive officer, and Scott
Ullem, chief financial officer, will also participate in the
conference. A live webcast of the presentation will be available on
the Edwards Lifesciences investor relations website at
http://ir.edwards.com/, with an archived version accessible later
the same day.
About Edwards
Lifesciences
Edwards Lifesciences is the global leader of patient-focused
innovations for structural heart disease and critical care
monitoring. We are driven by a passion for patients,
dedicated to improving and enhancing lives through partnerships
with clinicians and stakeholders across the global healthcare
landscape. For more information, visit Edwards.com and follow
us on Facebook, Instagram, LinkedIn, Twitter and YouTube.
Edwards, Edwards Lifesciences, and the stylized E logo are
trademarks of Edwards Lifesciences Corporation. All other
trademarks are the property of their respective owners.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/edwards-lifesciences-to-present-at-the-41st-annual-jp-morgan-healthcare-conference-301714286.html
SOURCE Edwards Lifesciences Corporation